Onartuzumab has been explored in clinical trials focusing on the treatment of various cancers, including neoplasms, lung cancer, glioblastoma, gastric cancer, and colorectal cancer. The DrugMonitor™ Anti-Onartuzumab Antibody (VS-1224-YC845) is an anti-drug antibody (ADA) against Onartuzumab. This drug-based antibody is raised in mice immunized with the Onartuzumab. The anti-Onartuzumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Onartuzumab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Anti-Human Met(Onartuzumab)Onartuzumab is a humanized monoclonal antibody designed for the treatment of cancer.
There are currently no Customer reviews or questions for VS-1224-YC845. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.